SOLACI-CACI 2021 | TCT II Session: Structural Heart Interventions

✔️ TCT Session in the SOLACI-CACI 2021 Congress.

👨‍🏫 Program:

  • 02:44 – Future of TAVR – Martin B. Leon
  • 36:27 – Future Developments in Trans-Catheter Mitral Valve Replacement – Juan F. Granada
  • 01:02:53 – Interventional Heart Failure – Dan Burkhoff

👉🏻 Chairperson: Aníbal Damonte & Jorge Belardi
👉🏻 Digital Moderator: Matías Sztejman
👉🏻 Panelists: Alcántara, Marco – Baccaro, Jorge -Barbagelata, Alejandro – Hurtado, Edgar – Leiva, Gustavo – Ribeiro, Henrique


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

SOLACI-CACI 2021 | SCAI Session

✔️ SCAI Session (Society for Cardiovascular Angiography and Interventions) in the SOLACI-CACI 2021 Congress. 👨‍🏫 Program: 00:03 - STEMI: Approach to Left Main Culprit -...

SOLACI-CACI 2021 | CRT Session: Live Case From Washington

✔️ Watch again the CRT Session in the SOLACI-CACI 2021 Congress. 👨‍🏫 Program: 00:03 - Live Case Medstar Washington Hospital Center - Operator: Lowel...

SOLACI-CACI 2021 | IAGS Session

✔️ Watch again the International Andreas Gruentzig Society (IAGS) Session in the SOLACI-CACI 2021 Congress. 👨‍🏫 Program: 03:08 - PCI and TAVR: Which Lesions...

SOLACI-CACI 2021 | CBS Session

✔️ Watch again the CBS Session in the SOLACI-CACI 2021 Congress. 👨‍🏫 Program: 00:01 - Live case from Nanjing First Hospital, NMU, Nanjing, China...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....